United Therapeutics paid its 4 named executives $46.3M in total in FY2025 (Dec). CEO Martine A. Rothblatt was paid $18.0M of that.
Pay$100 in the stock at the end of FY20 → $321
Pay of each named executive
Martine A. RothblattChairperson and Chief Executive Officer
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Michael BenkowitzPresident and Chief Operating Officer
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
James EdgemondChief Financial Officer and Treasurer
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Paul MahonExecutive Vice President and General Counsel
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
CEO pay against the pay peers
In FY2024 (Dec), the median CEO pay of the 11 peers with pay on file was $14.8M. The CEO of United Therapeutics was paid $23.0M, 55% above the median.
- 1Amgen
- 2Biogen
- 3Gilead Sciences
- 4United TherapeuticsThis company
- 5Incyte
- 6Jazz Pharmaceuticals
- 7Illumina
- 8Viatris
- 9Halozyme Therapeutics
- 10Alkermes plc.
- 11Neurocrine Biosciences
- 12Regeneron Pharmaceuticals
- 13Alnylam PharmaceuticalsNot disclosed
- 14BeiGeneNot disclosed
- 15BioMarin PharmaceuticalsNot disclosed
- 16ExelixisNot disclosed
- 17Horizon TherapeuticsNot disclosed
- 18Maraval Life SciencesNot disclosed
- 19ModernaNot disclosed
- 20Myriad GeneticsNot disclosed
- 21NovavaxNot disclosed
- 22PTC TherapeuticsNot disclosed
- 23Sarepta TherapeuticsNot disclosed
- 24Seattle GeneticsNot disclosed
- 25Syneos HealthNot disclosed
- 26Vertex PharmaceuticalsNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.